Premium
Continuous Monitoring Reveals Protective Effects of N ‐Acetylcysteine Amide on an Isogenic Microphysiological Model of the Neurovascular Unit
Author(s) -
Matthiesen Isabelle,
Voulgaris Dimitrios,
Nikolakopoulou Polyxeni,
Winkler Thomas E.,
Herland Anna
Publication year - 2021
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.202101785
Subject(s) - blood–brain barrier , induced pluripotent stem cell , glutathione , in vivo , biophysics , chemistry , biology , neuroscience , biochemistry , embryonic stem cell , microbiology and biotechnology , gene , enzyme , central nervous system
Microphysiological systems mimic the in vivo cellular ensemble and microenvironment with the goal of providing more human‐like models for biopharmaceutical research. In this study, the first such model of the blood‐brain barrier (BBB‐on‐chip) featuring both isogenic human induced pluripotent stem cell (hiPSC)‐derived cells and continuous barrier integrity monitoring with <2 min temporal resolution is reported. Its capabilities are showcased in the first microphysiological study of nitrosative stress and antioxidant prophylaxis. Relying on off‐stoichiometry thiol–ene–epoxy (OSTE+) for fabrication greatly facilitates assembly and sensor integration compared to the prevalent polydimethylsiloxane devices. The integrated cell–substrate endothelial resistance monitoring allows for capturing the formation and breakdown of the BBB model, which consists of cocultured hiPSC‐derived endothelial‐like and astrocyte‐like cells. Clear cellular disruption is observed when exposing the BBB‐on‐chip to the nitrosative stressor linsidomine, and the barrier permeability and barrier‐protective effects of the antioxidant N ‐acetylcysteine amide are reported. Using metabolomic network analysis reveals further drug‐induced changes consistent with prior literature regarding, e.g., cysteine and glutathione involvement. A model like this opens new possibilities for drug screening studies and personalized medicine, relying solely on isogenic human‐derived cells and providing high‐resolution temporal readouts that can help in pharmacodynamic studies.